Yanhong Shi, Ph.D., Beckman Research Institute of City of Hope. Progress is being made to treat cancer patients suffering from degenerative brain diseases. Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, have developed universal donor stem cells that could one day provide lifesaving therapy to … Continue reading Universal donor stem cells could one day provide lifesaving therapy for lethal brain conditions
stem cell research
Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
The California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, is pleased to announce the appointment of Kevin Xu to its Independent Citizens’ Oversight Committee (ICOC), the official governing Board of the agency. Xu is CEO of MEBO International, an intellectual property management company responsible for managing “Human Body Regenerative … Continue reading Kevin Xu joins governing board of California’s Stem Cell & Gene Therapy Agency
#Take6ForPD: CIRM Board member David Higgins shares why Parkinson’s awareness matters
April is Parkinson’s Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #Take6ForPD—take 6 minutes to raise Parkinson’s awareness and highlight our commitment to funding research for the disease. In addition to highlighting our commitment to funding research for Parkinson's Disease, we're also giving patients and patient advocates the opportunity to … Continue reading #Take6ForPD: CIRM Board member David Higgins shares why Parkinson’s awareness matters
CIRM commits $60 million for Parkinson’s research, joins #Take6ForPD awareness campaign
April is Parkinson’s Awareness Month and the California Institute for Regenerative Medicine (CIRM) is joining the campaign to #Take6ForPD—take 6 minutes to raise Parkinson’s awareness and highlight our commitment to funding research for the disease. What is Parkinson’s Disease? Parkinson's disease (PD) is a neurodegenerative disease that affects nearly 1 million people in the United States … Continue reading CIRM commits $60 million for Parkinson’s research, joins #Take6ForPD awareness campaign
CIRM welcomes two additions to its leadership team
Left to right: Rafael Aguirre-Sacasa, General Counsel and Koren Temple-Perry, Senior Director of Marketing Communications The California Institute for Regenerative Medicine (CIRM) continues to build its world class team to deliver the full potential of regenerative medicine to the people of California and around the world. CIRM is pleased to welcome two new members to its … Continue reading CIRM welcomes two additions to its leadership team
CIRM invests $2.7 million in research to develop stem cell-based tendon tissue for shoulder injuries
The California Institute for Regenerative Medicine (CIRM) has awarded a $2.7 million research grant to Scripps Health to investigate the use of stem cells to engineer rotator cuff tendons in the lab that can then be used to repair common shoulder injuries. The rotator cuff is a group of four muscles and their attached tendons, … Continue reading CIRM invests $2.7 million in research to develop stem cell-based tendon tissue for shoulder injuries
Investing in a stem cell treatment for Hurler syndrome
The California Institute for Regenerative Medicine (CIRM) awarded $5,444,353 to Dr. Natalia Gomez-Ospina and her team at Stanford University for a late-stage preclinical program targeting Severe Mucopolysaccharidosis type 1, also known as Hurler syndrome. This is an inherited condition caused by a faulty gene. Children with Hurler syndrome lack an enzyme that the body needs to digest … Continue reading Investing in a stem cell treatment for Hurler syndrome
Advancing cutting-edge treatment to improve kidney transplantation in children
Stanford physician-scientist Alice Bertaina, MD, PhD, associate professor of pediatrics has received about $18 million from the California Institute for Regenerative Medicine (CIRM) for a clinical trial to allow kidney transplantation without the need for long-term immunosuppression. Dr. Bertaina and her team at Stanford University were awarded $11,998,188 to test an approach that uses combined … Continue reading Advancing cutting-edge treatment to improve kidney transplantation in children
Funding development of a vaccine for acute myelogenous leukemia (AML)
Dr. Karin Gaensler. Photo credit: Steve Babuljak/UCSF Adult acute myelogenous leukemia—also known as acute myeloid leukemia (AML)—is a blood cancer in which the bone marrow makes a large number of abnormal blood cells. About 20,000 new cases of AML are diagnosed each year in the US with a 5-year survival rate of around 29%. In … Continue reading Funding development of a vaccine for acute myelogenous leukemia (AML)
The Most Read Stem Cellar Blog Posts of 2022
This year was a momentous one for the California Institute for Regenerative Medicine (CIRM). You can read some of our achievements in our 2021-2022 annual report. As always, we shared our most exciting updates and newsworthy stories—topics ranging from stem cell research to diversity in science—right here on The Stem Cellar. More than 100,000 blog … Continue reading The Most Read Stem Cellar Blog Posts of 2022